APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Antipyretic and Analgesic Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Research

Antipyretic and Analgesic Drugs Industry Research Report 2026

Report ID 173966500522 December 2025131 pages

Choose your research edition.

Industry ResearchAntipyretic and Analgesic Drugs Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Antipyretic and Analgesic Drugs Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Antipyretic and Analgesic Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antipyretic and Analgesic Drugs Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Antipyretic and Analgesic Drugs Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Antipyretic and Analgesic Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Antipyretic and Analgesic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Antipyretic and Analgesic Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Antipyretic and Analgesic Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Antipyretic and Analgesic Drugs include Yuanhe Pharmaceutical, Xinhui Pharmaceutical, Topfond Pharmaceutical, Taile Pharmaceutical, Sanofi, Pfizer, Kys Pharm, China Resources Double-Crane Pharmaceutical and Huaan Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Antipyretic and Analgesic Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Antipyretic and Analgesic Drugs Market by Company

Yuanhe Pharmaceutical

Xinhui Pharmaceutical

Topfond Pharmaceutical

Taile Pharmaceutical

Sanofi

Pfizer

Kys Pharm

China Resources Double-Crane Pharmaceutical

Huaan Pharmaceutical

Hongxing Pharmaceutical

Heping Pharmaceutical

China National Medicines Guorui Pharmaceutical

Dingchang Pharmaceutical

Baotai Pharmaceutical

Bayer

SKPL

Mallinckrodt

Antipyretic and Analgesic Drugs Segment by Type

Paracetamol

Naproxen

Ibuprofen

Analgin

Aspirin

Others

Antipyretic and Analgesic Drugs Segment by Application

Hospital

Clinic

Antipyretic and Analgesic Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antipyretic and Analgesic Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antipyretic and Analgesic Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antipyretic and Analgesic Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Antipyretic and Analgesic Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Antipyretic and Analgesic Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Antipyretic and Analgesic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Antipyretic and Analgesic Drugs Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Antipyretic and Analgesic Drugs Sales (k units) of Manufacturers (2021-2026) Table 7. Global Antipyretic and Analgesic Drugs Sales Market Share by Manufacturers (2021-2026) Table 8. Global Antipyretic and Analgesic Drugs Revenue of Manufacturers (2021-2026) Table 9. Global Antipyretic and Analgesic Drugs Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Antipyretic and Analgesic Drugs Average Price (US$/unit) of Manufacturers (2021-2026) Table 11. Global Antipyretic and Analgesic Drugs Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Antipyretic and Analgesic Drugs, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Antipyretic and Analgesic Drugs, Product Type & Application Table 14. Global Antipyretic and Analgesic Drugs Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Antipyretic and Analgesic Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Yuanhe Pharmaceutical Company Information Table 19. Yuanhe Pharmaceutical Business Overview Table 20. Yuanhe Pharmaceutical Antipyretic and Analgesic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 21. Yuanhe Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio Table 22. Yuanhe Pharmaceutical Recent Developments Table 23. Xinhui Pharmaceutical Company Information Table 24. Xinhui Pharmaceutical Business Overview Table 25. Xinhui Pharmaceutical Antipyretic and Analgesic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 26. Xinhui Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio Table 27. Xinhui Pharmaceutical Recent Developments Table 28. Topfond Pharmaceutical Company Information Table 29. Topfond Pharmaceutical Business Overview Table 30. Topfond Pharmaceutical Antipyretic and Analgesic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 31. Topfond Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio Table 32. Topfond Pharmaceutical Recent Developments Table 33. Taile Pharmaceutical Company Information Table 34. Taile Pharmaceutical Business Overview Table 35. Taile Pharmaceutical Antipyretic and Analgesic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 36. Taile Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio Table 37. Taile Pharmaceutical Recent Developments Table 38. Sanofi Company Information Table 39. Sanofi Business Overview Table 40. Sanofi Antipyretic and Analgesic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 41. Sanofi Antipyretic and Analgesic Drugs Product Portfolio Table 42. Sanofi Recent Developments Table 43. Pfizer Company Information Table 44. Pfizer Business Overview Table 45. Pfizer Antipyretic and Analgesic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Pfizer Antipyretic and Analgesic Drugs Product Portfolio Table 47. Pfizer Recent Developments Table 48. Kys Pharm Company Information Table 49. Kys Pharm Business Overview Table 50. Kys Pharm Antipyretic and Analgesic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 51. Kys Pharm Antipyretic and Analgesic Drugs Product Portfolio Table 52. Kys Pharm Recent Developments Table 53. China Resources Double-Crane Pharmaceutical Company Information Table 54. China Resources Double-Crane Pharmaceutical Business Overview Table 55. China Resources Double-Crane Pharmaceutical Antipyretic and Analgesic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 56. China Resources Double-Crane Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio Table 57. China Resources Double-Crane Pharmaceutical Recent Developments Table 58. Huaan Pharmaceutical Company Information Table 59. Huaan Pharmaceutical Business Overview Table 60. Huaan Pharmaceutical Antipyretic and Analgesic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Huaan Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio Table 62. Huaan Pharmaceutical Recent Developments Table 63. Hongxing Pharmaceutical Company Information Table 64. Hongxing Pharmaceutical Business Overview Table 65. Hongxing Pharmaceutical Antipyretic and Analgesic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Hongxing Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio Table 67. Hongxing Pharmaceutical Recent Developments Table 68. Heping Pharmaceutical Company Information Table 69. Heping Pharmaceutical Business Overview Table 70. Heping Pharmaceutical Antipyretic and Analgesic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Heping Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio Table 72. Heping Pharmaceutical Recent Developments Table 73. China National Medicines Guorui Pharmaceutical Company Information Table 74. China National Medicines Guorui Pharmaceutical Business Overview Table 75. China National Medicines Guorui Pharmaceutical Antipyretic and Analgesic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. China National Medicines Guorui Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio Table 77. China National Medicines Guorui Pharmaceutical Recent Developments Table 78. Dingchang Pharmaceutical Company Information Table 79. Dingchang Pharmaceutical Business Overview Table 80. Dingchang Pharmaceutical Antipyretic and Analgesic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Dingchang Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio Table 82. Dingchang Pharmaceutical Recent Developments Table 83. Baotai Pharmaceutical Company Information Table 84. Baotai Pharmaceutical Business Overview Table 85. Baotai Pharmaceutical Antipyretic and Analgesic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Baotai Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio Table 87. Baotai Pharmaceutical Recent Developments Table 88. Bayer Company Information Table 89. Bayer Business Overview Table 90. Bayer Antipyretic and Analgesic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Bayer Antipyretic and Analgesic Drugs Product Portfolio Table 92. Bayer Recent Developments Table 93. SKPL Company Information Table 94. SKPL Business Overview Table 95. SKPL Antipyretic and Analgesic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. SKPL Antipyretic and Analgesic Drugs Product Portfolio Table 97. SKPL Recent Developments Table 98. Mallinckrodt Company Information Table 99. Mallinckrodt Business Overview Table 100. Mallinckrodt Antipyretic and Analgesic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Mallinckrodt Antipyretic and Analgesic Drugs Product Portfolio Table 102. Mallinckrodt Recent Developments Table 103. Global Antipyretic and Analgesic Drugs Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 104. Global Antipyretic and Analgesic Drugs Sales by Region (2021-2026) & (k units) Table 105. Global Antipyretic and Analgesic Drugs Sales Market Share by Region (2021-2026) Table 106. Global Antipyretic and Analgesic Drugs Sales by Region (2027-2032) & (k units) Table 107. Global Antipyretic and Analgesic Drugs Sales Market Share by Region (2027-2032) Table 108. Global Antipyretic and Analgesic Drugs Revenue by Region (2021-2026) & (US$ Million) Table 109. Global Antipyretic and Analgesic Drugs Revenue Market Share by Region (2021-2026) Table 110. Global Antipyretic and Analgesic Drugs Revenue by Region (2027-2032) & (US$ Million) Table 111. Global Antipyretic and Analgesic Drugs Revenue Market Share by Region (2027-2032) Table 112. North America Antipyretic and Analgesic Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. North America Antipyretic and Analgesic Drugs Sales by Country (2021-2026) & (k units) Table 114. North America Antipyretic and Analgesic Drugs Sales by Country (2027-2032) & (k units) Table 115. North America Antipyretic and Analgesic Drugs Revenue by Country (2021-2026) & (US$ Million) Table 116. North America Antipyretic and Analgesic Drugs Revenue by Country (2027-2032) & (US$ Million) Table 117. Europe Antipyretic and Analgesic Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Europe Antipyretic and Analgesic Drugs Sales by Country (2021-2026) & (k units) Table 119. Europe Antipyretic and Analgesic Drugs Sales by Country (2027-2032) & (k units) Table 120. Europe Antipyretic and Analgesic Drugs Revenue by Country (2021-2026) & (US$ Million) Table 121. Europe Antipyretic and Analgesic Drugs Revenue by Country (2027-2032) & (US$ Million) Table 122. Asia Pacific Antipyretic and Analgesic Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Asia Pacific Antipyretic and Analgesic Drugs Sales by Country (2021-2026) & (k units) Table 124. Asia Pacific Antipyretic and Analgesic Drugs Sales by Country (2027-2032) & (k units) Table 125. Asia Pacific Antipyretic and Analgesic Drugs Revenue by Country (2021-2026) & (US$ Million) Table 126. Asia Pacific Antipyretic and Analgesic Drugs Revenue by Country (2027-2032) & (US$ Million) Table 127. South America Antipyretic and Analgesic Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. South America Antipyretic and Analgesic Drugs Sales by Country (2021-2026) & (k units) Table 129. South America Antipyretic and Analgesic Drugs Sales by Country (2027-2032) & (k units) Table 130. South America Antipyretic and Analgesic Drugs Revenue by Country (2021-2026) & (US$ Million) Table 131. South America Antipyretic and Analgesic Drugs Revenue by Country (2027-2032) & (US$ Million) Table 132. Middle East and Africa Antipyretic and Analgesic Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. Middle East and Africa Antipyretic and Analgesic Drugs Sales by Country (2021-2026) & (k units) Table 134. Middle East and Africa Antipyretic and Analgesic Drugs Sales by Country (2027-2032) & (k units) Table 135. Middle East and Africa Antipyretic and Analgesic Drugs Revenue by Country (2021-2026) & (US$ Million) Table 136. Middle East and Africa Antipyretic and Analgesic Drugs Revenue by Country (2027-2032) & (US$ Million) Table 137. Global Antipyretic and Analgesic Drugs Sales by Type (2021-2026) & (k units) Table 138. Global Antipyretic and Analgesic Drugs Sales by Type (2027-2032) & (k units) Table 139. Global Antipyretic and Analgesic Drugs Sales Market Share by Type (2021-2026) Table 140. Global Antipyretic and Analgesic Drugs Sales Market Share by Type (2027-2032) Table 141. Global Antipyretic and Analgesic Drugs Revenue by Type (2021-2026) & (US$ Million) Table 142. Global Antipyretic and Analgesic Drugs Revenue by Type (2027-2032) & (US$ Million) Table 143. Global Antipyretic and Analgesic Drugs Revenue Market Share by Type (2021-2026) Table 144. Global Antipyretic and Analgesic Drugs Revenue Market Share by Type (2027-2032) Table 145. Global Antipyretic and Analgesic Drugs Price by Type (2021-2026) & (US$/unit) Table 146. Global Antipyretic and Analgesic Drugs Price by Type (2027-2032) & (US$/unit) Table 147. Global Antipyretic and Analgesic Drugs Sales by Application (2021-2026) & (k units) Table 148. Global Antipyretic and Analgesic Drugs Sales by Application (2027-2032) & (k units) Table 149. Global Antipyretic and Analgesic Drugs Sales Market Share by Application (2021-2026) Table 150. Global Antipyretic and Analgesic Drugs Sales Market Share by Application (2027-2032) Table 151. Global Antipyretic and Analgesic Drugs Revenue by Application (2021-2026) & (US$ Million) Table 152. Global Antipyretic and Analgesic Drugs Revenue by Application (2027-2032) & (US$ Million) Table 153. Global Antipyretic and Analgesic Drugs Revenue Market Share by Application (2021-2026) Table 154. Global Antipyretic and Analgesic Drugs Revenue Market Share by Application (2027-2032) Table 155. Global Antipyretic and Analgesic Drugs Price by Application (2021-2026) & (US$/unit) Table 156. Global Antipyretic and Analgesic Drugs Price by Application (2027-2032) & (US$/unit) Table 157. Key Raw Materials Table 158. Raw Materials Key Suppliers Table 159. Antipyretic and Analgesic Drugs Distributors List Table 160. Antipyretic and Analgesic Drugs Customers List Table 161. Antipyretic and Analgesic Drugs Industry Trends Table 162. Antipyretic and Analgesic Drugs Industry Drivers Table 163. Antipyretic and Analgesic Drugs Industry Restraints Table 164. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Antipyretic and Analgesic Drugs Product Image Figure 5. Global Antipyretic and Analgesic Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Antipyretic and Analgesic Drugs Market Size (2021-2032) & (US$ Million) Figure 7. Global Antipyretic and Analgesic Drugs Sales (2021-2032) & (k units) Figure 8. Global Antipyretic and Analgesic Drugs Average Price (US$/unit) & (2021-2032) Figure 9. Paracetamol Product Image Figure 10. Naproxen Product Image Figure 11. Ibuprofen Product Image Figure 12. Analgin Product Image Figure 13. Aspirin Product Image Figure 14. Others Product Image Figure 15. Hospital Product Image Figure 16. Clinic Product Image Figure 17. Global Antipyretic and Analgesic Drugs Revenue Share by Manufacturers in 2025 Figure 18. Global Manufacturers of Antipyretic and Analgesic Drugs, Manufacturing Sites & Headquarters Figure 19. Global Top 5 and 10 Antipyretic and Analgesic Drugs Players Market Share by Revenue in 2025 Figure 20. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Antipyretic and Analgesic Drugs Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 22. Global Antipyretic and Analgesic Drugs Sales by Region in 2025 Figure 23. Global Antipyretic and Analgesic Drugs Revenue by Region in 2025 Figure 24. North America Antipyretic and Analgesic Drugs Market Size by Country in 2025 Figure 25. North America Antipyretic and Analgesic Drugs Sales Market Share by Country (2021-2032) Figure 26. North America Antipyretic and Analgesic Drugs Revenue Market Share by Country (2021-2032) Figure 27. United States Antipyretic and Analgesic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Canada Antipyretic and Analgesic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Mexico Antipyretic and Analgesic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Europe Antipyretic and Analgesic Drugs Market Size by Country in 2025 Figure 31. Europe Antipyretic and Analgesic Drugs Sales Market Share by Country (2021-2032) Figure 32. Europe Antipyretic and Analgesic Drugs Revenue Market Share by Country (2021-2032) Figure 33. Germany Antipyretic and Analgesic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. France Antipyretic and Analgesic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. U.K. Antipyretic and Analgesic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Italy Antipyretic and Analgesic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Russia Antipyretic and Analgesic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Spain Antipyretic and Analgesic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Netherlands Antipyretic and Analgesic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Switzerland Antipyretic and Analgesic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Sweden Antipyretic and Analgesic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Poland Antipyretic and Analgesic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Asia Pacific Antipyretic and Analgesic Drugs Market Size by Country in 2025 Figure 44. Asia Pacific Antipyretic and Analgesic Drugs Sales Market Share by Country (2021-2032) Figure 45. Asia Pacific Antipyretic and Analgesic Drugs Revenue Market Share by Country (2021-2032) Figure 46. China Antipyretic and Analgesic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Japan Antipyretic and Analgesic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. South Korea Antipyretic and Analgesic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. India Antipyretic and Analgesic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Australia Antipyretic and Analgesic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Taiwan Antipyretic and Analgesic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Antipyretic and Analgesic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Southeast Asia Antipyretic and Analgesic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. South America Antipyretic and Analgesic Drugs Market Size by Country in 2025 Figure 55. South America Antipyretic and Analgesic Drugs Sales Market Share by Country (2021-2032) Figure 56. South America Antipyretic and Analgesic Drugs Revenue Market Share by Country (2021-2032) Figure 57. Brazil Antipyretic and Analgesic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Argentina Antipyretic and Analgesic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Chile Antipyretic and Analgesic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Middle East and Africa Antipyretic and Analgesic Drugs Market Size by Country in 2025 Figure 61. Middle East and Africa Antipyretic and Analgesic Drugs Sales Market Share by Country (2021-2032) Figure 62. Middle East and Africa Antipyretic and Analgesic Drugs Revenue Market Share by Country (2021-2032) Figure 63. Egypt Antipyretic and Analgesic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. South Africa Antipyretic and Analgesic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Israel Antipyretic and Analgesic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Türkiye Antipyretic and Analgesic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. GCC Countries Antipyretic and Analgesic Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. Global Antipyretic and Analgesic Drugs Sales Market Share by Type (2021-2032) Figure 69. Global Antipyretic and Analgesic Drugs Revenue Market Share by Type (2021-2032) Figure 70. Global Antipyretic and Analgesic Drugs Price (US$/unit) by Type (2021-2032) Figure 71. Global Antipyretic and Analgesic Drugs Sales Market Share by Application (2021-2032) Figure 72. Global Antipyretic and Analgesic Drugs Revenue Market Share by Application (2021-2032) Figure 73. Global Antipyretic and Analgesic Drugs Price (US$/unit) by Application (2021-2032) Figure 74. Antipyretic and Analgesic Drugs Value Chain Figure 75. Antipyretic and Analgesic Drugs Production Mode & Process Figure 76. Direct Comparison with Distribution Share Figure 77. Distributors Profiles Figure 78. Antipyretic and Analgesic Drugs Industry Opportunities and Challenges

Scope & coverage.

Types
  • Paracetamol
  • Naproxen
  • Ibuprofen
  • Analgin
  • Aspirin
  • Others
Applications
  • Hospital
  • Clinic
Companies covered
  • Yuanhe Pharmaceutical
  • Xinhui Pharmaceutical
  • Topfond Pharmaceutical
  • Taile Pharmaceutical
  • Sanofi
  • Pfizer
  • Kys Pharm
  • China Resources Double-Crane Pharmaceutical
  • Huaan Pharmaceutical
  • Hongxing Pharmaceutical
  • Heping Pharmaceutical
  • China National Medicines Guorui Pharmaceutical
  • Dingchang Pharmaceutical
  • Baotai Pharmaceutical
  • Bayer
  • SKPL
  • Mallinckrodt

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Antipyretic and Analgesic Drugs Market Size (2021-2032)
  4. 2.2.2 Global Antipyretic and Analgesic Drugs Sales (2021-2032)
  5. 2.2.3 Global Antipyretic and Analgesic Drugs Market Average Price (2021-2032)
  6. 2.3 Antipyretic and Analgesic Drugs by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Paracetamol
  9. 2.3.3 Naproxen
  10. 2.3.4 Ibuprofen
  11. 2.3.5 Analgin
  12. 2.3.6 Aspirin
  13. 2.3.7 Others
  14. 2.4 Antipyretic and Analgesic Drugs by Application
  15. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  16. 2.4.2 Hospital
  17. 2.4.3 Clinic
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Antipyretic and Analgesic Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Antipyretic and Analgesic Drugs Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Antipyretic and Analgesic Drugs Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Antipyretic and Analgesic Drugs Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Antipyretic and Analgesic Drugs Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Antipyretic and Analgesic Drugs, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Antipyretic and Analgesic Drugs, Product Type & Application
  8. 3.8 Global Manufacturers of Antipyretic and Analgesic Drugs, Established Date
  9. 3.9 Global Antipyretic and Analgesic Drugs Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Yuanhe Pharmaceutical
  2. 4.1.1 Yuanhe Pharmaceutical Company Information
  3. 4.1.2 Yuanhe Pharmaceutical Business Overview
  4. 4.1.3 Yuanhe Pharmaceutical Antipyretic and Analgesic Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Yuanhe Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio
  6. 4.1.5 Yuanhe Pharmaceutical Recent Developments
  7. 4.2 Xinhui Pharmaceutical
  8. 4.2.1 Xinhui Pharmaceutical Company Information
  9. 4.2.2 Xinhui Pharmaceutical Business Overview
  10. 4.2.3 Xinhui Pharmaceutical Antipyretic and Analgesic Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Xinhui Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio
  12. 4.2.5 Xinhui Pharmaceutical Recent Developments
  13. 4.3 Topfond Pharmaceutical
  14. 4.3.1 Topfond Pharmaceutical Company Information
  15. 4.3.2 Topfond Pharmaceutical Business Overview
  16. 4.3.3 Topfond Pharmaceutical Antipyretic and Analgesic Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Topfond Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio
  18. 4.3.5 Topfond Pharmaceutical Recent Developments
  19. 4.4 Taile Pharmaceutical
  20. 4.4.1 Taile Pharmaceutical Company Information
  21. 4.4.2 Taile Pharmaceutical Business Overview
  22. 4.4.3 Taile Pharmaceutical Antipyretic and Analgesic Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Taile Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio
  24. 4.4.5 Taile Pharmaceutical Recent Developments
  25. 4.5 Sanofi
  26. 4.5.1 Sanofi Company Information
  27. 4.5.2 Sanofi Business Overview
  28. 4.5.3 Sanofi Antipyretic and Analgesic Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Sanofi Antipyretic and Analgesic Drugs Product Portfolio
  30. 4.5.5 Sanofi Recent Developments
  31. 4.6 Pfizer
  32. 4.6.1 Pfizer Company Information
  33. 4.6.2 Pfizer Business Overview
  34. 4.6.3 Pfizer Antipyretic and Analgesic Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Pfizer Antipyretic and Analgesic Drugs Product Portfolio
  36. 4.6.5 Pfizer Recent Developments
  37. 4.7 Kys Pharm
  38. 4.7.1 Kys Pharm Company Information
  39. 4.7.2 Kys Pharm Business Overview
  40. 4.7.3 Kys Pharm Antipyretic and Analgesic Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Kys Pharm Antipyretic and Analgesic Drugs Product Portfolio
  42. 4.7.5 Kys Pharm Recent Developments
  43. 4.8 China Resources Double-Crane Pharmaceutical
  44. 4.8.1 China Resources Double-Crane Pharmaceutical Company Information
  45. 4.8.2 China Resources Double-Crane Pharmaceutical Business Overview
  46. 4.8.3 China Resources Double-Crane Pharmaceutical Antipyretic and Analgesic Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 China Resources Double-Crane Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio
  48. 4.8.5 China Resources Double-Crane Pharmaceutical Recent Developments
  49. 4.9 Huaan Pharmaceutical
  50. 4.9.1 Huaan Pharmaceutical Company Information
  51. 4.9.2 Huaan Pharmaceutical Business Overview
  52. 4.9.3 Huaan Pharmaceutical Antipyretic and Analgesic Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Huaan Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio
  54. 4.9.5 Huaan Pharmaceutical Recent Developments
  55. 4.10 Hongxing Pharmaceutical
  56. 4.10.1 Hongxing Pharmaceutical Company Information
  57. 4.10.2 Hongxing Pharmaceutical Business Overview
  58. 4.10.3 Hongxing Pharmaceutical Antipyretic and Analgesic Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Hongxing Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio
  60. 4.10.5 Hongxing Pharmaceutical Recent Developments
  61. 4.11 Heping Pharmaceutical
  62. 4.11.1 Heping Pharmaceutical Company Information
  63. 4.11.2 Heping Pharmaceutical Business Overview
  64. 4.11.3 Heping Pharmaceutical Antipyretic and Analgesic Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Heping Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio
  66. 4.11.5 Heping Pharmaceutical Recent Developments
  67. 4.12 China National Medicines Guorui Pharmaceutical
  68. 4.12.1 China National Medicines Guorui Pharmaceutical Company Information
  69. 4.12.2 China National Medicines Guorui Pharmaceutical Business Overview
  70. 4.12.3 China National Medicines Guorui Pharmaceutical Antipyretic and Analgesic Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 China National Medicines Guorui Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio
  72. 4.12.5 China National Medicines Guorui Pharmaceutical Recent Developments
  73. 4.13 Dingchang Pharmaceutical
  74. 4.13.1 Dingchang Pharmaceutical Company Information
  75. 4.13.2 Dingchang Pharmaceutical Business Overview
  76. 4.13.3 Dingchang Pharmaceutical Antipyretic and Analgesic Drugs Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Dingchang Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio
  78. 4.13.5 Dingchang Pharmaceutical Recent Developments
  79. 4.14 Baotai Pharmaceutical
  80. 4.14.1 Baotai Pharmaceutical Company Information
  81. 4.14.2 Baotai Pharmaceutical Business Overview
  82. 4.14.3 Baotai Pharmaceutical Antipyretic and Analgesic Drugs Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Baotai Pharmaceutical Antipyretic and Analgesic Drugs Product Portfolio
  84. 4.14.5 Baotai Pharmaceutical Recent Developments
  85. 4.15 Bayer
  86. 4.15.1 Bayer Company Information
  87. 4.15.2 Bayer Business Overview
  88. 4.15.3 Bayer Antipyretic and Analgesic Drugs Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Bayer Antipyretic and Analgesic Drugs Product Portfolio
  90. 4.15.5 Bayer Recent Developments
  91. 4.16 SKPL
  92. 4.16.1 SKPL Company Information
  93. 4.16.2 SKPL Business Overview
  94. 4.16.3 SKPL Antipyretic and Analgesic Drugs Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 SKPL Antipyretic and Analgesic Drugs Product Portfolio
  96. 4.16.5 SKPL Recent Developments
  97. 4.17 Mallinckrodt
  98. 4.17.1 Mallinckrodt Company Information
  99. 4.17.2 Mallinckrodt Business Overview
  100. 4.17.3 Mallinckrodt Antipyretic and Analgesic Drugs Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Mallinckrodt Antipyretic and Analgesic Drugs Product Portfolio
  102. 4.17.5 Mallinckrodt Recent Developments
5 Global Antipyretic and Analgesic Drugs Market Scenario by Region
  1. 5.1 Global Antipyretic and Analgesic Drugs Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Antipyretic and Analgesic Drugs Sales by Region: 2021-2032
  3. 5.2.1 Global Antipyretic and Analgesic Drugs Sales by Region: 2021-2026
  4. 5.2.2 Global Antipyretic and Analgesic Drugs Sales by Region: 2027-2032
  5. 5.3 Global Antipyretic and Analgesic Drugs Revenue by Region: 2021-2032
  6. 5.3.1 Global Antipyretic and Analgesic Drugs Revenue by Region: 2021-2026
  7. 5.3.2 Global Antipyretic and Analgesic Drugs Revenue by Region: 2027-2032
  8. 5.4 North America Antipyretic and Analgesic Drugs Market Facts & Figures by Country
  9. 5.4.1 North America Antipyretic and Analgesic Drugs Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Antipyretic and Analgesic Drugs Sales by Country (2021-2032)
  11. 5.4.3 North America Antipyretic and Analgesic Drugs Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Antipyretic and Analgesic Drugs Market Facts & Figures by Country
  16. 5.5.1 Europe Antipyretic and Analgesic Drugs Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Antipyretic and Analgesic Drugs Sales by Country (2021-2032)
  18. 5.5.3 Europe Antipyretic and Analgesic Drugs Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Antipyretic and Analgesic Drugs Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Antipyretic and Analgesic Drugs Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Antipyretic and Analgesic Drugs Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Antipyretic and Analgesic Drugs Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Antipyretic and Analgesic Drugs Market Facts & Figures by Country
  41. 5.7.1 South America Antipyretic and Analgesic Drugs Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Antipyretic and Analgesic Drugs Sales by Country (2021-2032)
  43. 5.7.3 South America Antipyretic and Analgesic Drugs Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Antipyretic and Analgesic Drugs Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Antipyretic and Analgesic Drugs Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Antipyretic and Analgesic Drugs Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Antipyretic and Analgesic Drugs Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Antipyretic and Analgesic Drugs Sales by Type (2021-2032)
  2. 6.1.1 Global Antipyretic and Analgesic Drugs Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Antipyretic and Analgesic Drugs Sales Market Share by Type (2021-2032)
  4. 6.2 Global Antipyretic and Analgesic Drugs Revenue by Type (2021-2032)
  5. 6.2.1 Global Antipyretic and Analgesic Drugs Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Antipyretic and Analgesic Drugs Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Antipyretic and Analgesic Drugs Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Antipyretic and Analgesic Drugs Sales by Application (2021-2032)
  2. 7.1.1 Global Antipyretic and Analgesic Drugs Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Antipyretic and Analgesic Drugs Sales Market Share by Application (2021-2032)
  4. 7.2 Global Antipyretic and Analgesic Drugs Revenue by Application (2021-2032)
  5. 7.2.1 Global Antipyretic and Analgesic Drugs Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Antipyretic and Analgesic Drugs Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Antipyretic and Analgesic Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Antipyretic and Analgesic Drugs Value Chain Analysis
  2. 8.1.1 Antipyretic and Analgesic Drugs Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Antipyretic and Analgesic Drugs Production Mode & Process
  5. 8.2 Antipyretic and Analgesic Drugs Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Antipyretic and Analgesic Drugs Distributors
  8. 8.2.3 Antipyretic and Analgesic Drugs Customers
9 Global Antipyretic and Analgesic Drugs Analyzing Market Dynamics
  1. 9.1 Antipyretic and Analgesic Drugs Industry Trends
  2. 9.2 Antipyretic and Analgesic Drugs Industry Drivers
  3. 9.3 Antipyretic and Analgesic Drugs Industry Opportunities and Challenges
  4. 9.4 Antipyretic and Analgesic Drugs Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst